Many of the compounds in drugs cannot be effectively delivered using current drug delivery techniques (e.g., pills and injections). Transdermal delivery is an attractive alternative, but it is limited by the extremely low permeability of the skin. As the primary barrier to transport is located in the upper tissue, Micro-Electro-Mechanical-System (MEMS) technology provides novel means, such as microneedle array and PZT pump, in order to increase permeability of human skin with efficiency, safety and painless delivery, and to decrease the size of the pump. Microneedle array has many advantages, including minimal trauma at penetration site because of the small size of the needle, free from condition limitations, painless drug delivery, and precise control of penetration depth. These will promote the development of biomedical sciences and technology and make medical devices more humanized. So far, most of the insulin pumps being used are mechanical pumps. We present the first development of this novel technology, which can assemble the PZT pump and the microneedle array together for diabetes mellitus. The microneedle array based on a flexible substrate can be mounted on non-planar surface or even on flexible objects such as a human fingers and arms. The PZT pump can pump the much more precision drug accurately than mechanical pump and the overall size is much smaller than those mechanical pumps. The hollow wall straight microneedle array is fabricated on a flexible silicon substrate by inductively coupled plasma (ICP) and anisotropic wet etching techniques. The fabricated hollow microneedles are 200 μm in length and 30 μm in diameter. The microneedle array, which is built with on-board fluid pumps, has potential applications in the chemical and biomedical fields for localized chemical analysis, programmable drug-delivery systems, and very small, precise fluids sampling. The microneedle array has been installed in an insulin pump for demonstration and a leak free packaging is introduced.
Read full abstract